GSTM1 and head and neck squamous cell carcinoma: Some studies 1, 2, 3, 7, 26 have uncovered that low Hb levels prior to and during treatment have been associated with poor prognosis in HNSCC patients who were treated with radiotherapy; other studies 3, 25, 33 have shown that post‐RT Hb level was associated with survival.